Abstract
To forecast the incident cases of male breast cancer (MBC) in eight high-income European countries: France, Germany, Ireland, Italy, Netherlands, Spain, Sweden, and the United Kingdom over a 10-year period, and to report the expected stage at diagnosis and molecular subtype in these countries.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have